What's on the horizon for pancreatic cancer treatment and earlier detection? In this episode, host Alisyn Camerota sits down with Dr. Andrew Ko, professor of medicine and associate chief of hematology oncology at UC San Francisco, to explore the most promising advances in the field.

Dr. Ko breaks down the current state of pancreatic cancer vaccines and explains why they're showing promise for earlier stage patients following surgery. He also discusses the landscape of immunotherapy, the excitement around RAS inhibitors, and emerging targets. The conversation also covers early detection, including blood-based screening tools and the potential role of AI in identifying pancreatic cancer before symptoms appear.

Links:

Let's Win Pancreatic Cancer
PanCAN
PanCAN Patient Services
Let's Win Clinical Trial Finder
PanCAN Clinical Trial Finder